Direct Current Cardioversion in Pregnancy: A Multicenter Study

Obstetric Anesthesia Digest Pub Date : 2024-05-24 DOI:10.1097/01.aoa.0001016064.75927.1c

M. Cauldwell, D. Adamson, K. Bhatia, C. Bhagra, A. Bolger, T. Everett, C. Fox, J. Girling, C. Head, K. English, L. Hudsmith, R. James, M. Johnson, L. MacKiliop, F.M. McAuliffe, G. Mariappa, E. Orchard, M. O'Brien, F. Siddiqui, L. Simpson, M. Simpson, P. Timmons, S. Vause, G. Wander, N. Walker, P. Steer

{"title":"Direct Current Cardioversion in Pregnancy: A Multicenter Study","authors":"M. Cauldwell, D. Adamson, K. Bhatia, C. Bhagra, A. Bolger, T. Everett, C. Fox, J. Girling, C. Head, K. English, L. Hudsmith, R. James, M. Johnson, L. MacKiliop, F.M. McAuliffe, G. Mariappa, E. Orchard, M. O'Brien, F. Siddiqui, L. Simpson, M. Simpson, P. Timmons, S. Vause, G. Wander, N. Walker, P. Steer","doi":"10.1097/01.aoa.0001016064.75927.1c","DOIUrl":null,"url":null,"abstract":"(BJOG. 2023;130(10):1269–1274)\n The physiological changes that occur in pregnancy have been associated with new onset and recurrent cardiac arrhythmias. It is common for pregnant patients to experience palpitations in pregnancy, and most of these do not require treatment. However, some arrhythmias require treatment including medications and/or direct current cardioversion (DCCV) to restore the patient’s rhythm. In a recent inquiry into maternal deaths in the United Kingdom (UK), DCCV was not applied consistently and may have resulted in maternal deaths. This study aimed to understand practice surrounding DCCV in the UK, assessing which arrhythmias occurred and how they were treated. In addition, they evaluated outcomes associated with obstetric and neonatal health, including the use of fetal monitoring and whether there were cases where DCCV caused harm to the fetus.","PeriodicalId":19432,"journal":{"name":"Obstetric Anesthesia Digest","volume":"9 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obstetric Anesthesia Digest","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.aoa.0001016064.75927.1c","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

(BJOG. 2023;130(10):1269–1274) The physiological changes that occur in pregnancy have been associated with new onset and recurrent cardiac arrhythmias. It is common for pregnant patients to experience palpitations in pregnancy, and most of these do not require treatment. However, some arrhythmias require treatment including medications and/or direct current cardioversion (DCCV) to restore the patient’s rhythm. In a recent inquiry into maternal deaths in the United Kingdom (UK), DCCV was not applied consistently and may have resulted in maternal deaths. This study aimed to understand practice surrounding DCCV in the UK, assessing which arrhythmias occurred and how they were treated. In addition, they evaluated outcomes associated with obstetric and neonatal health, including the use of fetal monitoring and whether there were cases where DCCV caused harm to the fetus.

查看原文本刊更多论文

妊娠期直流电心脏起博器：一项多中心研究

(BJOG.2023;130(10):1269-1274) 妊娠期的生理变化与新发和复发性心律失常有关。妊娠期心悸是孕妇的常见症状，其中大多数不需要治疗。然而，有些心律失常需要治疗，包括药物和/或直流电心律转复术（DCCV）来恢复患者的心律。在最近对英国孕产妇死亡事件的调查中，DCCV 的应用并不一致，可能导致了孕产妇死亡。本研究旨在了解英国围绕 DCCV 的实践，评估发生了哪些心律失常以及如何治疗。此外，他们还评估了与产科和新生儿健康相关的结果，包括胎儿监护的使用情况以及 DCCV 是否对胎儿造成伤害。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Obstetric Anesthesia Digest

自引率

0.00%

发文量